Am J Perinatol
DOI: 10.1055/a-2570-3207
Review Article

New Approaches to Perinatal Depression

Authors

  • Katherine E. Cushman

    1   Hackensack Meridian School of Medicine, Nutley, New Jersey
  • Kanchi Chadha

    2   Department of Obstetrics and Gynecology, Hackensack University Medical Center, Hackensack, New Jersey
    3   Department of Obstetrics and Gynecology, Hackensack Meridian School of Medicine, Nutley, New Jersey
  • Yeraz Markarian

    4   Department of Psychiatry and Behavioral Health Services, Hackensack University Medical Center, Hackensack New Jersey
    5   Department of Psychiatry and Behavioral Health, Hackensack Meridian School of Medicine, Nutley, New Jersey
  • Carol A. Friedman

    4   Department of Psychiatry and Behavioral Health Services, Hackensack University Medical Center, Hackensack New Jersey
  • Antonia F. Oladipo

    2   Department of Obstetrics and Gynecology, Hackensack University Medical Center, Hackensack, New Jersey
    3   Department of Obstetrics and Gynecology, Hackensack Meridian School of Medicine, Nutley, New Jersey

Funding None.
Preview

Abstract

Perinatal depression (PD) is one of the most common complications of pregnancy and childbirth affecting as many as one out of five women in high-income countries. The prevalence is even higher in low- and middle-income countries. Untreated PD can result in serious short- and long-term negative effects on both the mother and newborn including adverse perinatal outcomes and negatively impacting mother–infant bonding, breastfeeding, and child neurocognitive development. Therefore, evaluation of the current standard of treatment is necessary. Historically, PD has lacked effective evidenced-based treatment guidelines. Current first-line treatment options include psychotherapy, psychopharmacology, or both, but lack specificity regarding good clinical practice guidelines. New approaches consist of a combination of early screening, preventative psychoeducation, optimizing timely diagnosis, and novel synergistic psychotherapy and psychopharmacology approaches to provide a comprehensive therapeutic approach. Future initiatives and research should evaluate improving screening tools, enhancing patient engagement, and exploring the efficacy of therapy utilizing multiple treatment modalities, to refine good clinical practice guidelines.

Key Points

  • PD is a common perinatal complication with potentially severe negative effects.

  • Early diagnosis and treatment of PD are vital for both mother and infant's health.

  • Future research is critical to improve screening and optimal management for PD.



Publication History

Received: 05 July 2024

Accepted: 31 March 2025

Accepted Manuscript online:
01 April 2025

Article published online:
22 April 2025

© 2025. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA